Bradley L A, Johnson D D, Palomaki G E, Haddow J E, Robertson N H, Ferrie R M
Foundation for Blood Research, Scarborough, Maine 04070-0190, USA.
J Med Screen. 1998;5(1):34-6. doi: 10.1136/jms.5.1.34.
This study aims to expand our knowledge of the general population frequency of two mutations, C282Y and H63D, identified in the candidate gene for hereditary haemochromatosis, and to determine whether the testing can be performed using routinely obtained cheek-brush (buccal) samples.
Banked buccal lysate samples, randomised and coded for anonymity, from a cohort of couples who underwent prenatal cystic fibrosis screening in Maine.
A multiplex ARMS test was performed on buccal cell lysates to identify the two mutations.
Genotype frequencies found among the 1001 subjects studied (502 women, 499 men) were: seven C282Y homozygotes, 22 C282Y/H63D compound heterozygotes, 97 C282Y heterozygotes, 17 H63D homozygotes, 246 H63D heterozygotes, and 612 individuals with no detectable mutation. The allele frequencies for C282Y and H63D were 0.066 and 0.151, respectively.
Observed genotype frequencies in Maine are consistent with expectations and with consensus data from five smaller studies. Combined mutational analysis data indicate that homozygosity for C282Y (the genotype found in about 85% of subjects with diagnosed hereditary haemochromatosis) occurs in 51 per 10,000 white subjects of northern European heritage; the corresponding total hereditary haemochromatosis prevalence of about 60 per 10,000 is consistent with previous estimates. The study also confirms that H63D would not be useful in general population screening for hereditary haemochromatosis.
本研究旨在拓展我们对遗传性血色素沉着症候选基因中鉴定出的两种突变(C282Y和H63D)在普通人群中出现频率的认识,并确定是否可以使用常规采集的颊刷(口腔)样本进行检测。
来自缅因州接受产前囊性纤维化筛查的一组夫妇的储存口腔裂解物样本,已随机编码以确保匿名性。
对口腔细胞裂解物进行多重扩增不应突变系统(ARMS)检测,以鉴定这两种突变。
在研究的1001名受试者(502名女性,499名男性)中发现的基因型频率为:7名C282Y纯合子、22名C282Y/H63D复合杂合子、97名C282Y杂合子、17名H63D纯合子、246名H63D杂合子以及612名未检测到突变的个体。C282Y和H63D的等位基因频率分别为0.066和0.151。
缅因州观察到的基因型频率与预期以及五项较小规模研究的共识数据一致。综合突变分析数据表明,C282Y纯合子(约85%被诊断为遗传性血色素沉着症的受试者中发现的基因型)在每10,000名具有北欧血统的白人受试者中出现的比例为51/10,000;相应的遗传性血色素沉着症总体患病率约为60/10,000,与先前的估计一致。该研究还证实,H63D一般不适用于遗传性血色素沉着症的人群筛查。